Gill Capital Partners’s Zomedica Corp. ZOM Stock Holding History

Gill Capital Partners’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2,719	Closed	-$272	–	688
2026 Q2	$272	Hold	2,719	–	–	﹤0.01%	666
2026 Q1	$325	Buy	+2,719	New	+$325	﹤0.01%	652

Other funds holding ZOM

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Gill Capital Partners's ZOM Position: Q3 2026 in Review

Gill Capital Partners sold out of Zomedica Corp. (ZOM) in Q3 2026, closing a stake of 2,719 shares — an estimated $272 sold.

Gill Capital Partners first reported a position in ZOM in Q1 2026 and held it in 2 quarters. The position peaked at $325 in Q1 2026. 1 fund tracked by Wall St. Rank holds ZOM as of Q3 2026.

Gill Capital Partners reported no remaining Zomedica Corp. position as of Q3 2026 after selling out during the quarter.
Gill Capital Partners sold 2,719 Zomedica Corp. shares in Q3 2026, an estimated $272.
Gill Capital Partners first reported a position in Zomedica Corp. in Q1 2026 and held it in 2 quarters.
Gill Capital Partners's Zomedica Corp. position peaked at $325 in Q1 2026.
1 fund tracked by Wall St. Rank held Zomedica Corp. as of Q3 2026.

Based on Gill Capital Partners's 13F filing for Q3 2026, filed 13 Oct 2026.